Because prescribing Ozempic for weight loss is an off-label use, many insurance companies will not cover Ozempic for weight loss
Mohammed Abdelrazek, Cytology and Histology Department, Faculty of Veterinary Medicine, Cairo University for his professional aid in the histopathology and analysis of this manuscript
However, research on optimal tapering schedules remains limited, and individual responses vary widely
Wegovy (semaglutide) is approved for adults with obesity, or who have overweight and have at least one weight-related health condition, like high blood pressure
We will discuss the risk of hypoglycemia, gastrointestinal side effects including previous reports on increased risk for pancreatitis and pancreas cancer, thyroid cancer, gallbladder stones, effects on the cardiovascular system, acute kidney injury, diabetic retinopathy risks and allergies/injection-site reactions ( Table 2 )